Sa’ad Shah

CaaMTech, a drug discovery company in the psychedelics space, has closed a $22 million Series A financing round. The company is focused on building a patent library of analytically pure, well-characterized psychedelic drugs for psychiatry and other health purposes. “We have been screening...